TELESAT CORP (TSAT) Fundamental Analysis & Valuation

NASDAQ:TSAT • CA8795123097

Current stock price

42.59 USD
-0.31 (-0.72%)
Last:

This TSAT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. TSAT Profitability Analysis

1.1 Basic Checks

  • In the past year TSAT has reported negative net income.
  • In the past year TSAT had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: TSAT reported negative net income in multiple years.
  • In the past 5 years TSAT always reported a positive cash flow from operatings.
TSAT Yearly Net Income VS EBIT VS OCF VS FCFTSAT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M -1B

1.2 Ratios

  • TSAT's Return On Assets of -2.35% is in line compared to the rest of the industry. TSAT outperforms 45.95% of its industry peers.
  • TSAT has a worse Return On Equity (-29.27%) than 67.57% of its industry peers.
  • TSAT's Return On Invested Capital of 1.38% is in line compared to the rest of the industry. TSAT outperforms 43.24% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for TSAT is below the industry average of 5.92%.
Industry RankSector Rank
ROA -2.35%
ROE -29.27%
ROIC 1.38%
ROA(3y)-0.37%
ROA(5y)0.03%
ROE(3y)-5.96%
ROE(5y)0.43%
ROIC(3y)2.65%
ROIC(5y)3.11%
TSAT Yearly ROA, ROE, ROICTSAT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 100

1.3 Margins

  • The Operating Margin of TSAT (13.71%) is comparable to the rest of the industry.
  • In the last couple of years the Operating Margin of TSAT has declined.
  • With an excellent Gross Margin value of 94.56%, TSAT belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
  • In the last couple of years the Gross Margin of TSAT has remained more or less at the same level.
Industry RankSector Rank
OM 13.71%
PM (TTM) N/A
GM 94.56%
OM growth 3Y-29.46%
OM growth 5Y-22.62%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.6%
GM growth 5Y-0.29%
TSAT Yearly Profit, Operating, Gross MarginsTSAT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. TSAT Health Analysis

2.1 Basic Checks

  • TSAT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, TSAT has more shares outstanding
  • Compared to 5 years ago, TSAT has less shares outstanding
  • Compared to 1 year ago, TSAT has a worse debt to assets ratio.
TSAT Yearly Shares OutstandingTSAT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
TSAT Yearly Total Debt VS Total AssetsTSAT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

  • TSAT has an Altman-Z score of 0.04. This is a bad value and indicates that TSAT is not financially healthy and even has some risk of bankruptcy.
  • TSAT has a worse Altman-Z score (0.04) than 86.49% of its industry peers.
  • A Debt/Equity ratio of 2.17 is on the high side and indicates that TSAT has dependencies on debt financing.
  • TSAT has a Debt to Equity ratio of 2.17. This is in the lower half of the industry: TSAT underperforms 75.68% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.17
Debt/FCF N/A
Altman-Z 0.04
ROIC/WACC0.24
WACC5.79%
TSAT Yearly LT Debt VS Equity VS FCFTSAT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B 2B 3B

2.3 Liquidity

  • TSAT has a Current Ratio of 0.25. This is a bad value and indicates that TSAT is not financially healthy enough and could expect problems in meeting its short term obligations.
  • TSAT has a worse Current ratio (0.25) than 97.30% of its industry peers.
  • TSAT has a Quick Ratio of 0.25. This is a bad value and indicates that TSAT is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of TSAT (0.25) is worse than 97.30% of its industry peers.
Industry RankSector Rank
Current Ratio 0.25
Quick Ratio 0.25
TSAT Yearly Current Assets VS Current LiabilitesTSAT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. TSAT Growth Analysis

3.1 Past

  • The earnings per share for TSAT have decreased strongly by -60.63% in the last year.
  • Looking at the last year, TSAT shows a very negative growth in Revenue. The Revenue has decreased by -26.81% in the last year.
  • The Revenue for TSAT have been decreasing by -12.62% on average. This is quite bad
EPS 1Y (TTM)-60.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-5.21%
Revenue 1Y (TTM)-26.81%
Revenue growth 3Y-18.04%
Revenue growth 5Y-12.62%
Sales Q2Q%-26.53%

3.2 Future

  • The Earnings Per Share is expected to decrease by -4.39% on average over the next years.
  • Based on estimates for the next years, TSAT will show a very strong growth in Revenue. The Revenue will grow by 31.28% on average per year.
EPS Next Y-54.1%
EPS Next 2Y-4.39%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-23.56%
Revenue Next 2Y-16.36%
Revenue Next 3Y0.94%
Revenue Next 5Y31.28%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
TSAT Yearly Revenue VS EstimatesTSAT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B
TSAT Yearly EPS VS EstimatesTSAT Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0 -2 -4 -6 -8 -10

More info and screens

Find the best growth stocksShow best growing peers

0

4. TSAT Valuation Analysis

4.1 Price/Earnings Ratio

  • TSAT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year TSAT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TSAT Price Earnings VS Forward Price EarningsTSAT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

  • 70.27% of the companies in the same industry are cheaper than TSAT, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 29.18
TSAT Per share dataTSAT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -10 -20

4.3 Compensation for Growth

  • TSAT's earnings are expected to decrease with -4.39% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-4.39%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. TSAT Dividend Analysis

5.1 Amount

  • No dividends for TSAT!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

TSAT Fundamentals: All Metrics, Ratios and Statistics

TELESAT CORP

NASDAQ:TSAT (4/7/2026, 2:50:40 PM)

42.59

-0.31 (-0.72%)

Chartmill FA Rating
GICS IndustryGroupTelecommunication Services
GICS IndustryDiversified Telecommunication Services
Earnings (Last)03-17
Earnings (Next)05-04
Inst Owners55.74%
Inst Owner Change0%
Ins Owners5.33%
Ins Owner Change0%
Market Cap2.18B
Revenue(TTM)417.96M
Net Income(TTM)-155.35M
Analysts80
Price Target76.33 (79.22%)
Short Float %7.74%
Short Ratio5.66
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-60.08%
Min EPS beat(2)-149.66%
Max EPS beat(2)29.51%
EPS beat(4)3
Avg EPS beat(4)51.33%
Min EPS beat(4)-149.66%
Max EPS beat(4)185.61%
EPS beat(8)5
Avg EPS beat(8)-183.25%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.47%
Min Revenue beat(2)-1.11%
Max Revenue beat(2)2.04%
Revenue beat(4)2
Avg Revenue beat(4)-0.12%
Min Revenue beat(4)-5.43%
Max Revenue beat(4)4.03%
Revenue beat(8)4
Avg Revenue beat(8)0.47%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)175.33%
PT rev (3m)51.68%
EPS NQ rev (1m)72.18%
EPS NQ rev (3m)68.49%
EPS NY rev (1m)0%
EPS NY rev (3m)-7.81%
Revenue NQ rev (1m)-2.41%
Revenue NQ rev (3m)-2.41%
Revenue NY rev (1m)-6.89%
Revenue NY rev (3m)-7.78%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 7.24
P/FCF N/A
P/OCF 45.37
P/B 5.7
P/tB N/A
EV/EBITDA 29.18
EPS(TTM)-6.31
EYN/A
EPS(NY)-9.72
Fwd EYN/A
FCF(TTM)-9.83
FCFYN/A
OCF(TTM)0.94
OCFY2.2%
SpS5.88
BVpS7.47
TBVpS-29.92
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -2.35%
ROE -29.27%
ROCE 1.74%
ROIC 1.38%
ROICexc 1.63%
ROICexgc 37.95%
OM 13.71%
PM (TTM) N/A
GM 94.56%
FCFM N/A
ROA(3y)-0.37%
ROA(5y)0.03%
ROE(3y)-5.96%
ROE(5y)0.43%
ROIC(3y)2.65%
ROIC(5y)3.11%
ROICexc(3y)3.3%
ROICexc(5y)4.01%
ROICexgc(3y)20.63%
ROICexgc(5y)18.82%
ROCE(3y)3.35%
ROCE(5y)3.93%
ROICexgc growth 3Y32.21%
ROICexgc growth 5Y10.24%
ROICexc growth 3Y-31.44%
ROICexc growth 5Y-25.2%
OM growth 3Y-29.46%
OM growth 5Y-22.62%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.6%
GM growth 5Y-0.29%
F-Score4
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 2.17
Debt/FCF N/A
Debt/EBITDA 5.59
Cap/Depr 513.87%
Cap/Sales 183.06%
Interest Coverage 0.31
Cash Conversion 32.35%
Profit Quality N/A
Current Ratio 0.25
Quick Ratio 0.25
Altman-Z 0.04
F-Score4
WACC5.79%
ROIC/WACC0.24
Cap/Depr(3y)462.11%
Cap/Depr(5y)312.32%
Cap/Sales(3y)132.45%
Cap/Sales(5y)89.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-60.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-5.21%
EPS Next Y-54.1%
EPS Next 2Y-4.39%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-26.81%
Revenue growth 3Y-18.04%
Revenue growth 5Y-12.62%
Sales Q2Q%-26.53%
Revenue Next Year-23.56%
Revenue Next 2Y-16.36%
Revenue Next 3Y0.94%
Revenue Next 5Y31.28%
EBIT growth 1Y-74.5%
EBIT growth 3Y-42.19%
EBIT growth 5Y-32.39%
EBIT Next Year317.44%
EBIT Next 3Y153.43%
EBIT Next 5Y103.26%
FCF growth 1Y33.36%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y6.79%
OCF growth 3Y-33.69%
OCF growth 5Y-29.1%

TELESAT CORP / TSAT Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for TELESAT CORP?

ChartMill assigns a fundamental rating of 2 / 10 to TSAT.


What is the valuation status of TELESAT CORP (TSAT) stock?

ChartMill assigns a valuation rating of 0 / 10 to TELESAT CORP (TSAT). This can be considered as Overvalued.


What is the profitability of TSAT stock?

TELESAT CORP (TSAT) has a profitability rating of 3 / 10.


Can you provide the expected EPS growth for TSAT stock?

The Earnings per Share (EPS) of TELESAT CORP (TSAT) is expected to decline by -54.1% in the next year.